e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
TBNET: tuberculosis research in Europe
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The risk of tuberculosis related to tumour necrosis factor antagonist therapies
I. Solovic (Vysne Hagy, Slovakia)
Source:
Annual Congress 2011 - TBNET: tuberculosis research in Europe
Session:
TBNET: tuberculosis research in Europe
Session type:
Symposium
Number:
1389
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Solovic (Vysne Hagy, Slovakia). The risk of tuberculosis related to tumour necrosis factor antagonist therapies. Annual Congress 2011 - TBNET: tuberculosis research in Europe
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1510-1512
Year: 2015
Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1512-1513
Year: 2015
Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Source: Eur Respir J 2010; 36: 1185-1206
Year: 2010
Tumor necrosis factor alpha inhibitors and reactivation of tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 281s
Year: 2007
Mycobacterial diseases developed during anti-tumour necrosis factor alpha therapy
Source: Eur Respir J 2014; 44: 1289-1295
Year: 2014
Tuberculosis and tumor necrosis factor alpha antagonist: Our experience
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 542s
Year: 2006
Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial
Source: Eur Respir J 2014; 43: 295-298
Year: 2004
Some of the tumor necrosis factor receptor superfamilies and their concentrations in serum during chemotherapy of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006
Using an interferon-γ assay for the diagnosis of tuberculosis infection before using tumor necrosis factor-α blockers
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
Source: Eur Respir J 2007; 30: 810-812
Year: 2007
Effects of zinc on the interleukin-1 and tumor necrosis factor in experimental silicosis
Source: Eur Respir J 2002; 20: Suppl. 38, 517s
Year: 2002
The levels of tumour necrosis factor-alpha and interleukin-1 in newly diagnosed and multi drug resistant tuberculosis
Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis
Year: 2004
Genetic polymorphism in the human tumor necrosis factor (
TNF
) and its association with different clinical types of tuberculosis disease in Peruvian patients
Source: Eur Respir J 2004; 24: Suppl. 48, 467s
Year: 2004
Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression?
Source: Eur Respir J 2007; 29: 8-10
Year: 2007
Vascular endothelial growth factor and tumor necrosis factor gene polymorphisms in Turkish patients with sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006
Tumour necrosis factor gene polymorphisms and childhood wheezing
Source: Eur Respir J 2005; 26: 637-646
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept